RAC 5.74% $1.73 race oncology ltd

Ann: Bisantrene shows potent anticancer activity in AML models, page-69

  1. 210 Posts.
    lightbulb Created with Sketch. 69
    Following on from this: could there be anticancer related functionality from restoring localised AKG by inhibiting FTO for any AKG dependent tumorgenesis pathways?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.